Risedronate case

Risedronate affaire What universities can learn from one of science’s biggest frauds From 1996 to 2013, Yoshihiro Sato, a Japanese bone-health researcher plagiarized work, fabricated data and forged authorships — prompting retractions of more than 60 studies in the scholarly literature so far. Grey and colleagues at the University of Auckland in New Zealand and the University of Aberdeen, UK, are among the researchers who have raised concerns about Sato’s work over the past decade or so, and they have studied the case in detail — in particular, how universities involved in the research investigated concerns about his work and allegations of misconduct Tides of lies The first thing that went through Alison Avenell's head when she heard Yoshihiro Sato had died was that it might be a trick. It was March 2017, and in the previous years, Avenell, a clinical nutritionist at the University of Aberdeen in the United Kingdom, had spent thousands of hours combing through Sato's papers, together with three colleagues in New Zealand. They had discovered that Sato, a bone researcher at a hospital in southern Japan, had fabricated data for dozens of clinical trials published in international journals

Retracted articles
Effect of risedronate on speed of sound in postmenopausal women with osteoporosis

Links
Are safe your medicines

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis